These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17076975)

  • 1. Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion.
    Asbell PA
    Curr Med Res Opin; 2006 Nov; 22(11):2149-57. PubMed ID: 17076975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of artificial tear formulation for patients with dry eye: where do we start?
    Tong L; Petznick A; Lee S; Tan J
    Cornea; 2012 Nov; 31 Suppl 1():S32-6. PubMed ID: 23038032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
    Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
    Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
    Jee D; Park SH; Kim MS; Kim EC
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board.
    Rolando M; Cantera E; Mencucci R; Rubino P; Aragona P
    Int Ophthalmol; 2018 Apr; 38(2):875-895. PubMed ID: 28397148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review.
    Ribeiro MVMR; Barbosa FT; Ribeiro LEF; Sousa-Rodrigues CF; Ribeiro EAN
    Arq Bras Oftalmol; 2019 Sep; 82(5):436-445. PubMed ID: 31508669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
    Perényi K; Dienes L; Kornafeld A; Kovács B; Kiss HJ; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
    J Ocul Pharmacol Ther; 2017; 33(6):487-492. PubMed ID: 28375789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
    Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
    Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease.
    Lee JH; Ahn HS; Kim EK; Kim TI
    Cornea; 2011 Feb; 30(2):175-9. PubMed ID: 21045674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations.
    Weng J; Fink MK; Sharma A
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of artificial tears on visual performance in subjects with dry eye.
    Ridder WH; Tomlinson A; Paugh J
    Optom Vis Sci; 2005 Sep; 82(9):835-42. PubMed ID: 16189494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular allergy and dry eye syndrome.
    Bielory L
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):421-4. PubMed ID: 15349042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the use of preservative-free topicals.
    Perry HD; Donnenfeld ED
    Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome.
    Sullivan LJ; McCurrach F; Lee S; Taylor HR; Rolando M; Marechal-Courtois C; Creuzot-Garcher C; Easty DL; Karabatsas C; Bingh Hoh M; Faschinger C; Laroche L
    Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
    Jee D; Park M; Lee HJ; Kim MS; Kim EC
    J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the clinical course of dry eye syndrome.
    Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
    Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.